Prevalence of Sarcopenia in Geriatric Patients

Sarcopenia Clinical Trial

Official title:

Prevalence of Sarcopenia in Patients Admitted to a Swiss University Department of Geriatric Medicine

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04124575
• Other study ID #: BASEC 2019-01461
• Status: Completed
• Start date: September 10, 2019
• Est. completion date: October 30, 2019

Study information

• Verified date: November 2019
• Source: University Department of Geriatric Medicine FELIX PLATTER
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

To assess the prevalence of sarcopenia among inpatients on acute geriatrics and geriatric rehabilitation wards of a Swiss university department of geriatric medicine using the most recent diagnosis definitions from european guidelines.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 350
• Est. completion date: October 30, 2019
• Est. primary completion date: October 30, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

• All patients >65 years old admitted to acute geriatrics and geriatric rehabilitation at the study site

Exclusion Criteria:

• Lack of informed written consent

• Implanted defibrillation device

• Acute Sepsis, severe volume overload or dehydration

• Life expectancy of < 3 months according to treating physician

• Unremovable bandages

• Patients in isolation rooms on the ward

• Measurement is not possible due to organizational reasons

• Inability to follow the procedures, e.g. due to language problems, psychological disorders

Related Conditions & MeSH terms

• Sarcopenia

Locations

Country	Name	City	State
Switzerland	University Department of Geriatric Medicine FELIX PLATTER	Basel

Sponsors (1)

Lead Sponsor	Collaborator
University Department of Geriatric Medicine FELIX PLATTER

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Presence of Sarcopenia (yes/no)	Using EWGSOP2 cut-off points	Baseline
Primary	Muscle quantity, measured by Body Impedance Analysis (kg)		Baseline
Primary	Hand Grip Strength (kPa)		Baseline
Primary	Gait Speed (m/s)		Baseline
Primary	Timed up and go Test (s)		Baseline
Secondary	Mini Mental Status (Score range from 0 to 30 Points; higher scores reflect better cognitive status)		Baseline
Secondary	Nutritional risk Screening (Score range from 0 to 7 Points; higher scores reflect higher risk of malnutrition)		Baseline
Secondary	Geriatric Depression Scale short version (Score range from 0 to 6 Points; higher scores reflect higher risk of depression)		Baseline
Secondary	Functional Independence Measure at Admission (Score range from 18 to 126 Points; higher scores reflect better functionality)		Baseline
Secondary	Calf and Mid-upper arm Circumference (cm)		Baseline
Secondary	Body Mass Index (kg/m^2)	Weight and height will be combined to report Body Mass Index in kg/m^2	Baseline